Boston T-Cell Party? News from #BiotechWeekBoston

Bioprocess International, Biopharm America and Cell & Gene Therapy combine for Biotech Week Boston.

Dan Stanton, Managing editor

September 10, 2019

1 Min Read
Boston T-Cell Party? News from #BiotechWeekBoston

Industry has convened in Boston this week to celebrate the success of biotech and discuss the bioprocesses of the future. Bioprocess Insider brings together the best of social media as Bioprocess International, Biopharm America and the Cell & Gene Therapy congress combine for #BiotechWeekBoston.

About the Author(s)

Dan Stanton

Dan Stanton

Managing editor

Journalist covering the international biopharmaceutical manufacturing and processing industries.


Founder and editor of Bioprocess Insider, a daily news offshoot of publication Bioprocess International, with expertise in the pharmaceutical and healthcare sectors, in particular, the following niches: CROs, CDMOs, M&A, IPOs, biotech, bioprocessing methods and equipment, drug delivery, regulatory affairs and business development.


From London, UK originally but currently based in Montpellier, France through a round-a-bout adventure that has seen me live and work in Leeds (UK), London, New Zealand, and China.

See more from Dan Stanton

You May Also Like

Webinars

ask the expert webcast
ATE Webcasts
More Product Faster: Maximize mAbs, Cell Therapy, and Gene Therapy Production with Upstream Process IntensificationMore Product Faster: Maximize mAbs, Cell Therapy, and Gene Therapy Production with Upstream Process Intensification
scientist at OPUS 80R
Sponsored Content
Reduce Risk and Enable Continuous Manufacturing Using Pre-Packed Columns for Multicolumn ChromatographyReduce Risk and Enable Continuous Manufacturing Using Pre-Packed Columns for Multicolumn Chromatography
Resilience logo
Sponsored Content
Built to Serve Innovation: A Briefing on Commercial Readiness at ResilienceBuilt to Serve Innovation: A Briefing on Commercial Readiness at Resilience
Latest Content
Sep 23 - Sep 26, 2024
Learn from the brightest minds in bioprocessing! The BPI US 2024 scientific agenda includes 200+ of the industry's top scientists to present the latest updates on how to improve efficiencies across all phases of biopharmaceutical development and production.
Learn More